Showing results (11-20 of 58) with videos related to

Sort By:
Pageof 6
Intervirology|March 5, 2009
Predictive value of the phosphorylation of signal transducers and activators of transcription in the outcome of interferon therapy for chronic hepatitis CHisamitsu Miyaaki, Tatsuki Ichikawa, Kazuhiko Nakao, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|June 3, 2017
PNPLA3 as a liver steatosis risk factor following living-donor liver transplantation for hepatitis CHisamitsu Miyaaki, Satoshi Miuma, Naota Taura, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|June 17, 2018
Utilization and efficacy of elbasvir/grazoprevir for treating hepatitis C virus infection after liver transplantationSatoshi Miuma, Hisamitsu Miyaaki, Akihiko Soyama, et al.
Oncology Letters|August 22, 2018
Serum exosomal microRNA-122 and microRNA-21 as predictive biomarkers in transarterial chemoembolization-treated hepatocellular carcinoma patientsTomoyuki Suehiro, Hisamitsu Miyaaki, Yasuko Kanda, et al.
Internal Medicine (Tokyo, Japan)|April 3, 2020
Influence of Interferon-free Direct-acting Antiviral Therapy on Primary Hepatocellular Carcinoma Recurrence: A Landmark Time Analysis and Time-dependent Extended Cox Proportional Hazards Model AnalysisSatoshi Miuma, Junya Miyamoto, Naota Taura, et al.
Hepatology International|September 15, 2016
Glucose fluctuations reduce quality of sleep and of life in patients with liver cirrhosisMasafumi Haraguchi, Hisamitsu Miyaaki, Tatsuki Ichikawa, et al.
Clinical Journal of Gastroenterology|July 21, 2015
Portal hypertensive gastropathy with portal thrombosis successfully treated with partial splenic embolizationHisamitsu Miyaaki, Tatsuki Ichikawa, Kazuhiko Nakao, et al.
Transplantation|June 13, 2018
Risk Factors and Clinical Course for Liver Steatosis or Nonalcoholic Steatohepatitis After Living Donor Liver TransplantationHisamitsu Miyaaki, Satoshi Miuma, Naota Taura, et al.
World Journal of Gastroenterology|August 19, 2007
Clearance of hepatitis C virus after living-donor liver transplantation in spite of residual viremia on end date of interferon therapy before transplantationTatsuki Ichikawa, Kazuhiko Nakao, Keisuke Hamasaki, et al.
Intervirology|January 14, 2010
Relationship between regulatory T cells and the combination of pegylated interferon and ribavirin for the treatment of chronic hepatitis type CMotohisa Akiyama, Tatuki Ichikawa, Hisamitsu Miyaaki, et al.
Pageof 6